Search Results - "van Gemert, Willemijn A M"

Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial by van Gemert, Willemijn A M, Schuit, Albertine J, van der Palen, Job, May, Anne M, Iestra, Jolein A, Wittink, Harriet, Peeters, Petra H, Monninkhof, Evelyn M

“…Physical inactivity and overweight are risk factors for postmenopausal breast cancer. The effect of physical activity may be partially mediated by concordant…”
Get full text

PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study by Banda, Amina, Privé, Bastiaan M, Allach, Youssra, Uijen, Maike J M, Peters, Steffie M B, Loeff, Cato C, Gotthardt, Martin, Muselaers, Constantijn H J, Witjes, J Alfred, van Oort, Inge M, Sedelaar, J P Michiel, Westdorp, Harm, Mehra, Niven, Khreish, Fadi, Ezziddin, Samer, Sabet, Amir, Kreissl, Michael C, Winkens, Thomas, Seifert, Philipp, Janssen, Marcel J R, van Gemert, Willemijn A M, Nagarajah, James

“…Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) is a novel treatment for patients with castration-resistant prostate cancer…”
Get full text

Quality of Life after Diet or Exercise-Induced Weight Loss in Overweight to Obese Postmenopausal Women: The SHAPE-2 Randomised Controlled Trial by van Gemert, Willemijn A M, van der Palen, Job, Monninkhof, Evelyn M, Rozeboom, Anouk, Peters, Roelof, Wittink, Harriet, Schuit, Albertine J, Peeters, Petra H

“…This study investigates the effect of a modest weight loss either by a calorie restricted diet or mainly by increased physical exercise on health related…”
Get full text

Thoughts on "Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?" by Privé, Bastiaan M, Peters, Steffie MB, Uijen, Maike JM, Janssen, Marcel JR, van Gemert, Willemijn AM, Kreissl, Michael C, Ezzidin, Samer, Konijnenberg, Mark W, Nagarajah, James

Get full text

Design of the SHAPE-2 study: the effect of physical activity, in addition to weight loss, on biomarkers of postmenopausal breast cancer risk by van Gemert, Willemijn A M, Iestra, Jolein I, Schuit, Albertine J, May, Anne M, Takken, Tim, Veldhuis, Wouter B, van der Palen, Job, Wittink, Harriët, Peeters, Petra H M, Monninkhof, Evelyn M

“…Physical inactivity and overweight are two known risk factors for postmenopausal breast cancer. Former exercise intervention studies showed that physical…”
Get full text

An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer by Privé, Bastiaan M., Muselaers, Constantijn H. J., van Oort, Inge M., Janssen, Marcel J. R., Peters, Steffie M. B., van Gemert, Willemijn A. M., Uijen, Maike J. M., Schilham, Melline M. G., Sedelaar, J. P. Michiel, Westdorp, Harm, Mehra, Niven, Gotthardt, Martin, Barentsz, Jelle O., Gerritsen, Winald R., Witjes, J. Alfred, Nagarajah, James

“…177 Lu-PSMA-617 radioligand therapy is a novel treatment for end-stage prostate cancer, which could also be applied to patients with hormone-sensitive prostate…”
Get full text

Prostaatspecifiek membraanantigeen radioligandtherapie met alfastralers, een review by Privé, Bastiaan M., van Gemert, Willemijn A. M., Nagarajah, James, Mehra, Niven, Gerritsen, Winald R., van Oort, Inge M., Gotthardt, Martin, Heskamp, Sandra, Janssen, Marcel J. R.

“…Samenvatting Prostaatspecifiek membraanantigeen (PSMA) radioligandtherapie is een veelbelovende experimentele behandeling voor gemetastaseerd…”
Get full text

Letter to the Editor RE: Tumor sink effect in 68 Ga-PSMA-11 PET: Myth or Reality? by Prive, Bastiaan M, Peters, Steffie, Uijen, Maike J M, Janssen, Marcel J R, van Gemert, Willemijn A M, Kreissl, Michael C, Ezziddin, Samer, Konijnenberg, Mark W, Nagarajah, James

Get full text

Humongous Seminal Vesicles on 68Ga-DOTATOC PET/CT: A Rare Presentation of a Neuroendocrine Tumor by Hendriks, Romee A., Hoogendoorn, Stefan P., van Gemert, Willemijn A.M., Kaal, Suzanne E.J., Arens, Anne I.J.

“…ABSTRACTA 24-year-old man presented with decreased appetite, fatigue, abdominal pain, and acute renal insufficiency. Ultrasound showed bilateral…”
Get full text

An Update to the Pilot Study of 177 Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer by Privé, Bastiaan M, Muselaers, Constantijn H J, van Oort, Inge M, Janssen, Marcel J R, Peters, Steffie M B, van Gemert, Willemijn A M, Uijen, Maike J M, Schilham, Melline M G, Sedelaar, J P Michiel, Westdorp, Harm, Mehra, Niven, Gotthardt, Martin, Barentsz, Jelle O, Gerritsen, Winald R, Witjes, J Alfred, Nagarajah, James

“…Lu-PSMA-617 radioligand therapy is a novel treatment for end-stage prostate cancer, which could also be applied to patients with hormone-sensitive prostate…”
Get full text

Abstract B70: Design of the SHAPE-2 trial; Effects of equivalent weight loss, with and without exercise, on postmenopausal breast cancer risk by Gemert, Willemijn AM van, Peeters, Petra HM, Schuit, Jantine A., Monninkhof, Evelyn M.

“…Abstract Background: Physical inactivity and overweight are two modifiable risk factors for breast cancer. These factors probably act through sex…”
Get full text